Abvc Biopharma ABVC
NASDAQ ABVC
$0.90 -0.08 (-8.16%)
At close: Nov 13, 2026 · 4:00 PM EST

Abvc Biopharma (ABVC) Liabilities and Shareholders Equity (2009 - 2026)

Updated

Abvc Biopharma (ABVC) recorded Liabilities and Shareholders Equity of $20.3 million in Q3 2026, down 4.3% from $21.21 million a year earlier but up 4.6% from the prior quarter.

Analysis

Abvc Biopharma (ABVC) Liabilities and Shareholders Equity (2009 - 2026) Analysis & Trends

At the end of FY2025, Abvc Biopharma reported Liabilities and Shareholders Equity of $21.82 million, up 189.4% from FY2024.

  • Annual Liabilities and Shareholders Equity has a five-year compound annual growth rate of 13.5% (FY2020 to FY2025).
  • Across earlier years, Liabilities and Shareholders Equity came in at $7.54 million in FY2024 (-3.1%), $7.78 million in FY2023 (-18.7%), $9.58 million in FY2022 (-30.1%) and $13.7 million in FY2021 (+18.0%).
  • Quarterly Liabilities and Shareholders Equity has ranged from $7.54 million in Q4 2024 to $21.82 million in Q4 2025 over the past five years.
  • On a year-over-year basis, Liabilities and Shareholders Equity rose in six of the last eight quarters, with growth averaging 74.4%.
  • Peak year-over-year performance for Liabilities and Shareholders Equity in the last five years was growth of 189.4% in Q4 2025, against a decline of 53.1% in Q3 2024 at the low end.
  • Per Business Quant, the preceding three quarters came in at $19.4 million (Q2 2026), $19.73 million (Q1 2026) and $21.82 million (Q4 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Liabilities and Shareholders Equity (Qtr)
1 Eli Lilly 1,359.75 Bn 1,333.37 Bn 20.46 Bn 148.07 Bn
2 Johnson & Johnson 688.76 Bn 608.62 Bn 17.30 Bn 197.43 Bn
3 AbbVie 521.69 Bn 489.75 Bn 13.12 Bn 147.68 Bn
4 Merck 364.31 Bn 327.31 Bn 13.19 Bn 132.77 Bn
5 Novartis Ag 306.35 Bn 279.93 Bn - -
6 Astrazeneca 285.96 Bn 259.56 Bn 13.26 Bn 119.92 Bn
7 Amgen 251.88 Bn 203.53 Bn 7.58 Bn 96.05 Bn
8 Gilead Sciences 208.59 Bn 183.61 Bn 6.73 Bn 51.41 Bn
9 Pfizer 164.73 Bn 112.38 Bn 12.56 Bn 205.00 Bn
10 Abvc Biopharma 24.28 Mn 21.86 Mn - 20.30 Mn
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2026 20.30 Mn
Jun 30, 2026 19.40 Mn
Mar 31, 2026 19.73 Mn
Dec 31, 2025 21.82 Mn
Sep 30, 2025 21.21 Mn
Jun 30, 2025 16.24 Mn
Mar 31, 2025 14.88 Mn
Dec 31, 2024 7.54 Mn
Sep 30, 2024 7.78 Mn
Jun 30, 2024 8.04 Mn
Mar 31, 2024 7.98 Mn
Dec 31, 2023 7.78 Mn
Sep 30, 2023 16.59 Mn
Jun 30, 2023 9.32 Mn
Mar 31, 2023 10.73 Mn
Dec 31, 2022 9.58 Mn
Sep 30, 2022 10.48 Mn
Jun 30, 2022 13.78 Mn
Mar 31, 2022 12.07 Mn
Dec 31, 2021 13.70 Mn
API Access

Abvc Biopharma Liabilities and Shareholders Equity API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=liabilities-and-shareholders-equity&ticker=ABVC&period=max&api_key=YOUR_API_KEY